4 results for month: 08/2019


RAKFOND NOMINATED FOR THE “HEADLINER OF THE YEAR” PRIZE

RakFond will participate in the competition for the "Headliner of the Year" National Prize in the "Science and Education" category. Voting will be open between October 16 and December 15, 2019. Please support us!

New interview with Kristina Zakurdaeva about the prospects of cancer control on “Russia 24” TV channel

The interviewee is a hematologist and the Founder of RakFond Kristina Zakurdaeva, MD, PhD. The interview is in Russian, with no translation available...

HOW FRAGILE ARE THE CLINICAL TRIALS SUPPORTING APPROVAL OF NOVEL ANTICANCER MEDICINES

A new article, recently published in The Lancet Oncology, raises a question of the fragility of phase 3, randomized, controlled trials supporting anticancer drugs that were approved by the FDA...

Interview with Andrei Gudkov

Interview with Andrei Gudkov, Ph.D., D.Sci., Senior Vice President, Research Technology and Innovation, Chair, Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA), Member of RakFond's Scientific Advisory Board... Learn about the relationship between cancer and evolution, what the scientists may be proud of, and where the curiosity leads us...